Promis Neurosciences Inc (PMN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 2,779 | -13,213 | -18,062 | -9,790 | -4,227 |
| Depreciation Amortization | N/A | 21 | 11 | 46 | 12 |
| Accounts receivable | N/A | N/A | N/A | N/A | 26 |
| Accounts payable and accrued liabilities | -6,106 | 4,963 | 2,676 | -32 | N/A |
| Other Working Capital | -11,730 | 2,945 | 5,403 | -1,564 | 655 |
| Other Operating Activity | -12,126 | -5,560 | -7,061 | 2,035 | 284 |
| Operating Cash Flow | $-27,182 | $-10,844 | $-17,034 | $-9,305 | $-3,251 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -1 | -1 | 0 | 0 | 0 |
| PPE Investments | N/A | N/A | -2 | 92 | -81 |
| Purchase Of Investment | N/A | N/A | N/A | N/A | -2 |
| Other Investing Activity | 0 | 0 | 0 | 2 | 0 |
| Investing Cash Flow | $-1 | $-1 | $-2 | $95 | $-84 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 6,915 | N/A |
| Common Stock Issued | 27,876 | 17,749 | 6,495 | 18,608 | 2,862 |
| Financing Cash Flow | $27,876 | $17,749 | $6,495 | $25,523 | $2,862 |
| Exchange Rate Effect | N/A | -181 | -527 | -175 | N/A |
| Beginning Cash Position | 12,598 | 5,876 | 16,944 | 807 | 1,241 |
| End Cash Position | 13,291 | 12,598 | 5,876 | 16,944 | 768 |
| Net Cash Flow | $693 | $6,722 | $-11,068 | $16,137 | $-472 |
| Free Cash Flow | |||||
| Operating Cash Flow | -27,182 | -10,844 | -17,034 | -9,305 | -3,251 |
| Capital Expenditure | N/A | N/A | -2 | -6 | -81 |
| Free Cash Flow | -27,182 | -10,844 | -17,036 | -9,311 | -3,332 |